You are here

Article Text

Article menu

Download PDFPDF

Video article
Robotic pelvic and para-aortic retroperitoneal lymph nodes staging for early-stage epithelial ovarian cancer
Free
  1. Déborah Couet,
  2. Bérengère Tate,
  3. Huyên-Thu Nguyen-Xuan,
  4. Meriem Koual,
  5. Anne-Sophie Bats,
  6. Henri Azais and
  7. Enrica Bentivegna
  1. Gynecologic and Breast Oncologic Surgery Department, Georges Pompidou European Hospital, APHP. Centre, Paris Cité University, Paris, France
  1. Correspondence to Dr Henri Azais, Gynecologic and Breast Oncologic Surgery, Hopital Europeen Georges Pompidou, Paris, Île-de-France, France; henri.azais{at}aphp.fr

https://doi.org/10.1136/ijgc-2022-003948

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The objective of this video is to present a complete pelvic and para-aortic lymph node staging by retroperitoneal robotic-assisted laparoscopy of an early-stage epithelial ovarian cancer.1

    We present the case of a 38-year-old patient who was diagnosed with an infiltrative subtype mucinous ovarian cancer stage IA. Fertility sparing surgery was indicated provided there was no lymph node involvement. A pelvic and para-aortic lymph node dissection was realized for staging purposes.

    The video features the following steps to perform the retroperitoneal procedure by robot-assisted laparoscopy.2 After locating the anatomic landmarks, we dissect the right common iliac artery caudally to the bifurcation of the external iliac artery and internal iliac artery and cranially to the left renal vein. We then dissect the inferior vena cava from the intersection with the right ureter to the left renal veins. Overall, we performed a complete para-aortic, left and right lymphadenectomies. A final view with all of the elements (ie, bifurcation of the common iliac artery, the left renal vein, and both ureters) is provided. They were no complications in the short and medium term.

    The surgery permits a complete lymphadenectomy with correct lymph node dissection to be performed. The negative lymph node staging keeps the patient in stage IA and allows the patient to preserve her uterus and the contralateral ovary without adjuvant treatment. The retroperitoneal staging by robotic assisted laparoscopy avoids the abdominal cavity with intestinal loops and possible adhesions. This approach is also beneficial in the context of previous laparotomy surgery combined with high body mass index (ie, 28 kg/m2).

    The realization of pelvic and para-aortic lymph node dissection with retroperitoneal robot-assisted laparoscopy is feasible and mini-invasive surgery is beneficial for the patient.3

    Figure 1
    Figure 1

    Complete pelvic and para-aortic lymph node staging by a robotic approach.

    Video 1 Robotic pelvic and para-aortic retroperitoneal lymph node staging for early-stage epithelial ovarian cancer.

    Data availability statement

    There are no data in this work.

    Ethics statements

    Patient consent for publication

    Ethics approval

    Not applicable.

    References

    1. ↵
      2. Yao G ,
      3. Jin X
      . Impact of lymphadenectomy on outcomes of early-stage ovarian cancer: a systematic review and meta-analysis. Front Surg 2021;8.doi:10.3389/fsurg.2021.682348 pmid:http://www.ncbi.nlm.nih.gov/pubmed/34169090
    2. ↵
      2. Bentivegna E ,
      3. Koual M ,
      4. Nguyen-Xuan H-T , et al
      . Docking for robotic extraperitoneal para-aortic lymphadenectomy with Da Vinci XI surgical system. J Gynecol Obstet Hum Reprod 2021;50.doi:10.1016/j.jogoh.2021.102131 pmid:http://www.ncbi.nlm.nih.gov/pubmed/33781970
    3. ↵
      2. Bebia V ,
      3. Gil-Moreno A ,
      4. Hernández A , et al
      . Robot-assisted extraperitoneal para-aortic lymphadenectomy is associated with fewer surgical complications: a post hoc analysis of the STELLA-2 randomized trial. J Minim Invasive Gynecol 2021;28:2004–12.doi:10.1016/j.jmig.2021.05.009 pmid:http://www.ncbi.nlm.nih.gov/pubmed/34022445
      OpenUrlPubMed

    Footnotes

    • Twitter @Henriaz

    • Contributors DC: Writing - original draft preparation, visualization. BT: Writing - original draft preparation, visualization. H-TN-Xu, MK, ASB: Supervision. HA: Supervision, methodology, conceptualization, guarantor. EB: Supervision, conceptualization.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests EB reported being employed by Intuitive Surgical Inc (proctoring).

    • Provenance and peer review Not commissioned; externally peer reviewed.